Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against V.F. Corporation (VFC), Fluor Corporation (FLR), and Cytokinetics, Incorporated (CYTK)
ATLANTA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:
V.F. Corporation (VFC)
The shareholder class action lawsuit filed against V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts concerning VFC’s turnaround plan, Reinvent, between October 30, 2023 and May 20, 2025. If you purchased VFC shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-68T32 or you may visit the firm’s website at www.holzerlaw.com/case/vfc/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is November 12, 2025.
Fluor Corporation (FLR)
The shareholder class action lawsuit filed against Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding costs associated with the Gordie Howe, I-635/LBJ, and I-35 projects between February 18, 2025 and July 31, 2025. If you purchased Fluor shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/fluor/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is November 14, 2025.
Cytokinetics, Incorporated (CYTK)
The shareholder class action lawsuit filed against Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding its NDA for aficamten between December 27, 2023 and May 6, 2025. If you purchased Cytokinetics shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/cytokinetics/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is November 17, 2025.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
